Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 21 - 30 of 128

Selected Filters:
25 April 2024

Coordinating Implementation Science: Taking Stock of PrEP Evidence

This document summarises key takeaways from the BioPIC Think Tank held in March 2024 to review existing PrEP evidence and evidence gaps to date.

Research

Document
9 April 2024

Opportunities for Pharmacist-Delivered Injectable PrEP in the USA

These Quick Take briefings from Georgetown University’s O’Neill Institute for National and Global Health Law provide insights on barriers and opportunities for pharmacist-administered injectable PrEP in the USA, including delivery via mobile pharmacies.

Research, Service Delivery

Document
8 April 2024

MOSAIC – PrEP Site Implementation and New Product Readiness Assessment Tool

This tool is intended to provide insight into the current state of PrEP services and to identify critical barriers and facilitators to PrEP implementation. Additionally, this tool is designed to inform preparations for new PrEP product introduction (CAB PrEP, PrEP ring, or both) according to national priorities. Findings from readiness assessment visits using this tool…

Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

Spreadsheet
2 April 2024

Private Sector Market Assessment: Eswatini

This market assessment explores the opportunities and barriers to leveraging private sector channels to expand access to new and existing pre-exposure prophylaxis (PrEP) methods, including oral PrEP, the dapivirine vaginal ring (PrEP ring), and long acting cabotegravir (CAB PrEP) in Eswatini.

Service Delivery

Document
1 April 2024

CAB PrEP Introduction Situation Analysis – Zimbabwe – 2023

This document summarizes findings from the national situation analysis that can support the creation of a national biomedical HIV prevention platform. It aims to clarify critical steps for the introduction of biomedical HIV prevention products.

Service Delivery

Document
26 March 2024

Discussing Early Results from the SEARCH Dynamic Choice Study

Watch the recording. Join AVAC and Professor Moses Kamya of Makerere University to find out why the early results of the SEARCH Dynamic Choice study were some of the most exciting to come out of CROI in 2024. Conducted in Kenya and Uganda, the study offered oral PrEP, PEP or injectable cabotegravir to both men…

Research

Event
5 March 2024

CATALYST Interim Learnings (May-November 2023)

In this first interim analysis, the MOSAIC team provides key learnings from preparing for the delivery of PrEP choice, a summary of challenges experienced in implementing the enhanced service delivery model and the solutions introduced, programmatic considerations for countries preparing to introduce new PrEP methods, and a list of publicly accessible tools and resources used…

Research

Document
4 March 2024

Coordinating Implementation Science for CAB for PrEP: Early Insights from EBONI and PILLAR

This document summarises key takeaways from the BioPIC Think Tank on early insights from ViiV Healthcare’s two cabotegravir for PrEP implementation studies- EBONI and PILLAR.

Research, Service Delivery

Document
29 February 2024

CAB PrEP Introduction Situation Analysis – Eswatini – 2023

This document summarizes findings from the national situation analysis that can support the creation of a national biomedical HIV prevention platform.

Normative Guidance/Policies, Research

Document
29 February 2024

CAB PrEP Introduction Situation Analysis – Kenya – 2023

This document summarizes findings from the national situation analysis that can support the creation of a national biomedical HIV prevention platform.

Normative Guidance/Policies, Research

Document